HC
GILD icon

Hurley Capital’s Gilead Sciences GILD Stock Holding History

Hurley Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.3K Buy
519
+1
+0.2% +$140 0.04% 151
2025
Q4 		$63.6K Sell
518
-10
-2% -$1.22K 0.04% 155
2025
Q3 		$58.6K Buy
528
+10
+2% +$1.14K 0.03% 180
2025
Q2 		$57.4K Hold
518
– – 0.04% 146
2025
Q1 		$58K Buy
518
+358
+224% +$36.9K 0.04% 157
2024
Q4 		$15.5K Buy
+160
New +$14.4K 0.01% 243

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hurley Capital's GILD Position: Q1 2026 in Review

Hurley Capital increased its Gilead Sciences (GILD) stake by 0.19% in Q1 2026, buying an estimated $140 and bringing the position to 519 shares worth $72.3K. The position accounts for 0.04% of the portfolio, ranked #151.

Hurley Capital first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hurley Capital held 519 shares of Gilead Sciences worth $72.3K as of Q1 2026.
  • Hurley Capital bought 1 Gilead Sciences share in Q1 2026, an estimated $140.
  • Gilead Sciences made up 0.04% of Hurley Capital's portfolio in Q1 2026, its #151 holding.
  • Hurley Capital first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.